Hextar Healthcare Bhd (XKLS:7803) EBIT: RM-35.8 Mil (TTM As of Mar. 2026)


What is Hextar Healthcare Bhd EBIT?

Hextar Healthcare Bhd XKLS:7803 EBIT is RM-35.8 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Hextar Healthcare Bhd's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was RM-2.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was RM-35.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Hextar Healthcare Bhd's annualized ROC % for the quarter that ended in Mar. 2026 was -2.27%. Hextar Healthcare Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -4.88%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Hextar Healthcare Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -94.25%.

Hextar Healthcare Bhd  (XKLS:7803) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Hextar Healthcare Bhd's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-9.824 * ( 1 - 0% )/( (440.827 + 422.824)/ 2 )
=-9.824/431.8255
=-2.27 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=477.803 - 13.104 - ( 23.872 - max(0, 22.806 - 132.762+23.872))
=440.827

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=473.846 - 19.155 - ( 31.867 - max(0, 22.423 - 129.933+31.867))
=422.824

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Hextar Healthcare Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-10.776/( ( (169.689 + max(64.648, 0)) + (168.85 + max(38.856, 0)) )/ 2 )
=-10.776/( ( 234.337 + 207.706 )/ 2 )
=-10.776/221.0215
=-4.88 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(20.125 + 44.363 + 21.126) - (13.104 + 0 + 7.862)
=64.648

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(14.302 + 43.709 + 0) - (19.155 + 0 + -3.5527136788005E-15)
=38.856

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Hextar Healthcare Bhd's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-35.809/37.992
=-94.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hextar Healthcare Bhd EBIT Related Terms

Hextar Healthcare Bhd EBIT Historical Data

* Premium members only.

The historical data trend for Hextar Healthcare Bhd's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hextar Healthcare Bhd EBIT Chart

Hextar Healthcare Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 236.89 -62.98 -73.14 -18.72 -35.13

Hextar Healthcare Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.03 -6.64 -5.33 -21.14 -2.69

XKLS:7803 vs LIN, SHW, ECL: EBIT Comparison

For the Specialty Chemicals subindustry, Hextar Healthcare Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hextar Healthcare Bhd EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Hextar Healthcare Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hextar Healthcare Bhd's EV-to-EBIT falls into.


Hextar Healthcare Bhd EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-35.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of RM-35.8 Mil mean?
Hextar Healthcare Bhd (XKLS:7803) has a EBIT of RM-35.8 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Hextar Healthcare Bhd.
Is Hextar Healthcare Bhd's EBIT too high?
Hextar Healthcare Bhd's current EBIT is RM-35.8 Mil.
How does Hextar Healthcare Bhd's EBIT compare to LIN and SHW?
Hextar Healthcare Bhd's EBIT of RM-35.8 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Hextar Healthcare Bhd. Hextar Healthcare Bhd's current EBIT is RM-35.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hextar Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Hextar Healthcare Bhd (XKLS:7803) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.16, compared to a current price of RM0.06 — trading 62.5% below its estimated fair value. The current EBIT is RM-35.8 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Hextar Healthcare Bhd (XKLS:7803), the current EBIT is RM-35.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hextar Healthcare Bhd Business Description

Address Jalan Bercham, Lot 138201, Off 3/4 Mile, Kawasan Perindustrian Bercham, Ipoh, PRK, MYS, 31400
Hextar Healthcare Bhd is principally involved in investment holding. Through its subsidiaries, it manufactures and sells rubber gloves. The company offers a wide range of industrial and safety gloves, household rubber gloves, and disposable vinyl and nitrile gloves. The company operates in three segments: Gloves operation, Medical devices operation, and Investment holding. The company generates the majority of its revenue from the Gloves operation segment. It has operations in Europe, Asia, North and South America, and the Rest of the world.